[1] Tsang J Y S, Tse G M. Molecular classification of breast cancer[J]. Advances in Anatomic Pathology, 2019, 27(1):27-35. [2] Jafari S H, Saadatpour Z, Salmaninejad A, et al. Breast cancer diagnosis:Imaging techniques and biochemical markers[J]. Journal of Cellular Physiology, 2018, 233(7):5200-5213. [3] Guo R R, Lu G L, Qin B J, et al. Ultrasound imaging technologies for breast cancer detection and management:A review[J]. Ultrasound in Medicine & Biology, 2018, 44(1):37-70. [4] Geisel J, Raghu M, Hooley R. The role of ultrasound in breast cancer screening:The case for and against ultrasound[J]. Seminars in Ultrasound, CT, and MR, 2018, 39(1):25-34. [5] Kim Y, Kim S H, Song B J, et al. Early prediction of response to neoadjuvant chemotherapy using dynamic contrast-enhanced MRI and ultrasound in breast cancer[J]. Korean Journal of Radiology, 2018, 19(4):682-691. [6] Wang M, Feng H L, Liu Y Q, et al. Angiogenesis research in mouse mammary cancer based on contrast-enhanced ultrasonography[J]. Academic Radiology, 2018, 25(7):889-897. [7] 徐平,杨敏,刘勇,等. 超声造影定性及定量分析鉴别乳腺良恶性非肿块型病变[J]. 中国医学影像技术, 2020, 36(12):1825-1829. [8] Kuhl C K, Lehman C, Bedrosian I. Imaging in locoregional management of breast cancer[J]. Journal of Clinical Oncology, 2020, 38(20):2351-2361. [9] Marinovich M L, Hunter K E, MacAskill P, et al. Breast cancer screening using tomosynthesis or mammography:A meta-analysis of cancer detection and recall[J]. Journal of the National Cancer Institute, 2018, 110(9):942-949. [10] Miller A B. The role of screening mammography in the era of modern breast cancer treatment[J]. Climacteric, 2018, 21(3):204-208. [11] Mann R M, Cho N, Moy L. Breast MRI:State of the art[J]. Radiology, 2019, 292(3):520-536. [12] 刘芳欣, 郑慧, 王洲. 声触诊弹性成像定量技术及超声造影在鉴别诊断乳腺非肿块型良恶性病变中的应用价值[J]. 安徽医科大学学报, 2019, 54(2):286-291. [13] Tong W J, Zhang X L, Luo J, et al. Value of multimodality imaging in the diagnosis of breast lesions with calcification:a retrospective study[J]. Clinical Hemorheology and Microcirculation, 2020, 76(1):85-98. [14] 韩龄锋. 多模态超声联合评分法对乳腺非肿块型病变的诊断价值[D]. 泸州:西南医科大学, 2018. [15] Li M, Li Q, Yin Q, et al. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer[J]. Clinical and Translational Oncology, 2020, 23(4):709-717. [16] 朱庆莉, 姜玉新, 孙强,等. 乳腺癌彩色多普勒血流显像的多因素分析[J]. 中华超声影像学杂志, 2006, 15(2):109-112. [17] Li X, Li Y, Zhu Y, et al. Association between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancer[J]. Oncology Letters, 2018, 15(4):5643-5649. [18] Liu J, Gao Y H, Li D D, et al.Comparative study of contrast-enhanced ultrasound qualitative and quantitative analysis for identifying benign and malignant breast tumor lumps[J]. Asian Pacific Journal of Cancer Prevention,2014, 15(19):8149-8153. [19] 王媚瑜, 张一峰, 陈捷, 等.超声造影定量分析技术在乳腺导管内病变良恶性鉴别中的应用价值[J]. 上海交通大学学报(医学版), 2020, 40(4):514-518. [20] Lehotska V, Rauova K, Vanovcanova L. Pitfalls of contrast enhanced ultrasound (CEUS) in determination of breast tumor biological dignity[J]. Neoplasma, 2018, 65(1):124-131. |